Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

BACKGROUND: Transferring results obtained in cardiovascular outcome trials (CVOTs) to the real-world setting is challenging. We herein transposed CVOT results to the population of patients with type 2 diabetes (T2D) seen in routine clinical practice and who may receive the medications tested in CVOT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciannameo, V., Berchialla, P., Avogaro, A., Fadini, G. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112047/
https://www.ncbi.nlm.nih.gov/pubmed/33971880
http://dx.doi.org/10.1186/s12933-021-01300-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112047/
https://www.ncbi.nlm.nih.gov/pubmed/33971880
http://dx.doi.org/10.1186/s12933-021-01300-y

Ejemplares similares